Describe the burdens associated with IBD and the limitations of conventional therapies, including nonresponse, relapse, and adverse effects Assess the immune and inflammatory mechanisms involved in the pathogenesis of IBD, including IL-12 and IL-23 pathways and the relationship between CD64 and IL-23 Evaluate the latest clinical data and treatment implications associated with approved and late-stage investigational interleukin inhibitors for IBD, including real-world evidence for optimal use and sequencing
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/24-aibdr-105
- Start Date: 2024-10-05 05:00:00
- End Date: 2024-10-05 05:00:00
- Credit Details: IPCE Credits: 0.75 hours
AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest